Skip to content

Bruker BRKR Other operating expenses

Other operating expenses at other companies

TEC
Bio-TechneTECH
Illumina logo
IlluminaILMN
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
Onto Innovation logo
Onto InnovationONTO
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX

Other financials

Income statement

See full
Revenue$823.4M+2.7%
Gross profit$379.8M-2.9%
Operating income$10.2M-67.9%
Net income$14.4M-17.2%
EPS (diluted)$0.02-81.8%

Balance sheet

See full
Cash & equivalents$137.6M-26.7%
Total debt$1.7B-20.9%
Total equity$2.5B+34.6%
Total assets$6.1B+3.3%

Cash flow

See full
Operating cash flow$71.2M+9.5%
CapEx$24.2M-6.9%
Free cash flow$47.0M+20.5%

Valuation

See full
Market cap$8.71B-13.2%
Enterprise value$10.25B-14.9%
P/S2.5×-0.4×

Profitability

See full
Gross margin45.3%-3.7pp
Operating margin1.3%-5.0pp
Net margin-0.6%-10.0pp
FCF margin1.5%-3.6pp

Returns & leverage

See full
Return on equity-1%-21.2pp
Debt / equity0.7×-0.5×
Current ratio1.6×0.0×

Where this comes from

Reported directly by Bruker in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The official record: Bruker’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bruker's other operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bruker's other operating expenses?
Bruker (BRKR) reported other operating expenses of $369.6M in Q1 2026.
How has Bruker's other operating expenses changed year-over-year?
Bruker's other operating expenses increased by 2.8% year-over-year, from $359.4M to $369.6M.
What is the long-term trend for Bruker's other operating expenses?
Over 4 years (2021 to 2025), Bruker's other operating expenses has grown at a 17.3% compound annual growth rate (CAGR), from $796.3M to $1.51B.